Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512491-35-00

Enrollment

Registered

2024-06-14

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autosomal Dominant Polycystic kidney disease (ADPKD), cronic kidney disease

Brief summary

MRI signature of the kidney

Detailed description

Measures of kidney function in blood and urine., Expired CO2 measures

Interventions

DRUGHyperpolarized [1-13C]pyruvate

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
MRI signature of the kidney	—

Secondary

Measure	Time frame
Measures of kidney function in blood and urine., Expired CO2 measures	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026